Top Undervalued Stocks To Buy Now: 5 Dividend Paying Covid-19 Stock Investment Strategies
Top 5 Undervalued High Dividend Covid-19 Vaccine Stocks To Buy Now š Free Investing Training Today: http://learn.investdiva.com/yes š· See if you qualify to join the PIGš·š https://learn.investdiva.com/hello
My goal today is to stay away from the hype and shine a light on the covid 19 vaccine-related stocks that have a lower chance of being a boom or bust, have a wider economic moat which would help them knock down their competitors and stay on top over the long run, even after the whole pandemic thing is behind us, those that are currently undervalued which means you can buy them at an optimal price today or those that at least pay a fair amount of dividend so you can earn some cash on a quarterly basis while riding out the hype.
Number 5 on the list is Johnson & Johnson (JNJ) which is one of the largest companies on the list and pays one of the highest dividend payments at a 2.69% yield but its stock price hasnāt been performing very well since 2017.
Number 4 on my underrated Covid-19 vaccine-related stocks is Regeneron Pharmaceuticals (REGN). This company discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation.
Number 3 on the list is GlaxoSmithKline (GSK) which is one of the largest pharmaceutical companies by total sales. GSK has a 93 billion dollar market cap and pays a whopping 5.41% dividend yield but because the stock price is kinda cheap, this dividend yield only amounts to $2 per share per year.
Number 3 (tied) is Honeywell International (HON). It pays a 1.75% dividend yield and its earnings per share are healthy but it's overvalued right now.
Number 2 is Eli Lilly (LLY) for its wide economic moat, fair dividend payment, and fair current market value.
The top spot is reserved for two companies that check all the boxes that come to this type of filtering. And the spot is tied between two companies; Merck and Amgen. Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive care products. Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections, and some argue it owns one of the best drugs in the world, Keytruda.
#Stocks #investing #topstocks
Create your
podcast in
minutes
It is Free